PreventionRx
Status:Completed
Phase:Open Label
Principal Investigator(s):Jared Baeten
Objective:Multi-component, targeted hiv prevention for sub-Saharan Africa. Effect of evidence-based behavioural and biomeical preventative interventions on HIV incidence.
Prevention Option(s):Treatment U=U, VMMC
Study Design:Controlled, Randomized
Trial Sponsors:
International Clinical Research Center, University of Washington
Start Date
End Date
January 1, 2009
December 31, 2013
Enrollment:0
Age range:
↔
any
Population:Cisgender Men, Cisgender Women, People Living with HIV